Icad Inc Stock Investor Sentiment

ICAD Stock  USD 2.06  0.07  3.52%   
About 55% of Icad's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding icad inc suggests that some traders are interested. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
  

Icad Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at news.google.com         
Analyzing iCAD and Health Sciences Acquisitions Co. 2 - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretatio...
Yahoo News
over six months ago at simplywall.st         
iCAD Full Year 2023 Earnings EPS Beats Expectations, Revenues Lag
Simply Wall St News at Macroaxis
over six months ago at insidermonkey.com         
iCAD, Inc. Q4 2023 Earnings Call Transcript
insidermonkey News
over six months ago at finance.yahoo.com         
iCAD, Inc. Q4 2023 Earnings Call Transcript
Yahoo News
over six months ago at seekingalpha.com         
iCAD Non-GAAP EPS of -0.02 beats by 0.03, revenue of 4.74M beats by 0.46M
seekingalpha News
over six months ago at finance.yahoo.com         
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
Yahoo News
over six months ago at news.google.com         
Is iCAD Inc Stock at the Top of the Medical Devices Industry - InvestorsObserver
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Investors in iCAD from three years ago are still down 87, even after 44 percent gain this past week
Yahoo News
over six months ago at www.macroaxis.com         
Acquisition by Susan Wood of 3879 shares of Icad subject to Rule 16b-3
Macroaxis News
over six months ago at simplywall.st         
iCAD, Inc. Stock Rockets 26 percent As Investors Are Less Pessimistic Than Expected
Simply Wall St News at Macroaxis
over six months ago at finance.yahoo.com         
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates...
Yahoo News
over six months ago at seekingalpha.com         
ICAD stock jumps 11 percent ahead of medical meeting presentations
seekingalpha News
over six months ago at globenewswire.com         
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates...
Macroaxis News: globenewswire.com
over six months ago at benzinga.com         
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates...
benzinga news
Far too much social signal, news, headlines, and media speculation about Icad that are available to investors today. That information is available publicly through Icad media outlets and privately through word of mouth or via Icad internal channels. However, regardless of the origin, that massive amount of Icad data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icad alpha.

Icad Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
iCAD adds US15m to market cap in the past 7 days, though investors from three years ago are still down 82
10/17/2024
2
Acquisition by Hricak Hedvig of 40000 shares of Icad at 1.36 subject to Rule 16b-3
11/05/2024
3
iCAD Non-GAAP EPS of -0.07 beats by 0.01, revenue of 4.2M misses by 0.42M
11/13/2024
4
icad Inc Q3 2024 Earnings Call Highlights Revenue Growth Amidst Strategic Shifts
11/14/2024
5
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024
11/26/2024
6
CORRECTION iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA ...
12/04/2024
7
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial Calcifications Assessment Across Diverse Populations
12/11/2024
8
iCAD Stock Crosses Above 200 Day Moving Average Should You Sell
01/03/2025

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stocks Directory
Find actively traded stocks across global markets